Goldman Sachs
MED icon

Goldman Sachs’s Medifast MED Stock Holding History

Goldman Sachs’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,300
Closed -$2.35M – 5616
2020
Q3 		$2.35M Sell
14,300
-113,100
-89% -$18.6M ﹤0.01% 3451
2020
Q2 		$17.7M Buy
127,400
+117,400
+1,174% +$10.8M 0.01% 1779
2020
Q1 		$625K Buy
+10,000
New +$910K ﹤0.01% 4075
2019
Q4 		– Sell
-17,300
Closed -$1.79M – 5336
2019
Q3 		$1.79M Buy
+17,300
New +$1.86M ﹤0.01% 3610

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Goldman Sachs's MED Position: Q1 2026 in Review

Goldman Sachs reduced its Medifast (MED) stake by 15% in Q1 2026, selling an estimated $299K and leaving 153,171 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4747.

Goldman Sachs first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.1M in Q3 2018. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Goldman Sachs held 153,171 shares of Medifast worth $1.56M as of Q1 2026.
  • Goldman Sachs sold 27,692 Medifast shares in Q1 2026, an estimated $299K.
  • Medifast made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4747 holding.
  • Goldman Sachs first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Medifast position peaked at $56.1M in Q3 2018.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.